263 related articles for article (PubMed ID: 11550142)
21. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
Li HY; Ren GS; Arnould N; Brettes JP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828
[TBL] [Abstract][Full Text] [Related]
22. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
[TBL] [Abstract][Full Text] [Related]
23. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
24. High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients.
Vincent-Salomon A; Hajage D; Rouquette A; Cédenot A; Gruel N; Alran S; Sastre-Garau X; Sigal-Zafrani B; Fourquet A; Kirova Y
Breast; 2012 Jun; 21(3):380-3. PubMed ID: 22531230
[TBL] [Abstract][Full Text] [Related]
25. Lobular neoplasia on core needle biopsy does not require excision.
Nagi CS; O'Donnell JE; Tismenetsky M; Bleiweiss IJ; Jaffer SM
Cancer; 2008 May; 112(10):2152-8. PubMed ID: 18348299
[TBL] [Abstract][Full Text] [Related]
26. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
27. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies.
Gao F; Carter G; Tseng G; Chivukula M
Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524
[TBL] [Abstract][Full Text] [Related]
28. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
29. Lobular carcinoma in situ (LCIS): pathology and treatment.
Gump FE
J Cell Biochem Suppl; 1993; 17G():53-8. PubMed ID: 8007710
[TBL] [Abstract][Full Text] [Related]
30. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?
Cutuli B; de Lafontan B; Quetin P; Mery E
Eur J Cancer; 2005 Feb; 41(3):380-5. PubMed ID: 15691636
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological survey of preinvasive breast cancer.
Vandenbroucke A; Bourdon C
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
[TBL] [Abstract][Full Text] [Related]
32. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of lobular neoplasia on breast core biopsy.
Karabakhtsian RG; Johnson R; Sumkin J; Dabbs DJ
Am J Surg Pathol; 2007 May; 31(5):717-23. PubMed ID: 17460455
[TBL] [Abstract][Full Text] [Related]
34. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status.
Stolier AJ; Barre G; Bolton JS; Fuhrman GM; Looney S
Am Surg; 2004 Sep; 70(9):818-21. PubMed ID: 15481302
[TBL] [Abstract][Full Text] [Related]
35. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
Goldstein NS
Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
[TBL] [Abstract][Full Text] [Related]
36. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
[TBL] [Abstract][Full Text] [Related]
37. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.
Rasbridge SA; Gillett CE; Sampson SA; Walsh FS; Millis RR
J Pathol; 1993 Feb; 169(2):245-50. PubMed ID: 8383197
[TBL] [Abstract][Full Text] [Related]
38. Lobular carcinoma, not only a classic.
Brogi E; Murray MP; Corben AD
Breast J; 2010; 16 Suppl 1():S10-4. PubMed ID: 21050299
[TBL] [Abstract][Full Text] [Related]
39. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
Huang E; Buchholz TA; Meric F; Krishnamurthy S; Mirza NQ; Ames FC; Feig BW; Kuerer HM; Ross MI; Singletary SE; McNeese MD; Strom EA; Hunt KK
Cancer; 2002 Nov; 95(10):2059-67. PubMed ID: 12412158
[TBL] [Abstract][Full Text] [Related]
40. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
